Hyro
PrivateLast Round
Strategic Growth
Round
Oct 21, 2025
Est. Valuation
$244.5M
Total Funding Raised
$95M
Momentum Score
50 /100
Company Overview
Hyro is a technology company that has developed an AI-powered Adaptive Communications Platform designed to automate and simplify interactions across digital channels. The company primarily serves the healthcare industry, enabling organizations to streamline workflows and patient communications for tasks such as scheduling, prescription refills, and answering frequently asked questions. Hyro's platform utilizes a combination of proprietary natural language processing and large language models to deploy voice and text-based AI assistants on call centers, websites, and mobile apps. The stated mission is to help companies and their customers communicate more easily and effectively, improving operational efficiencies and patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, Patient Engagement, Workflow Automation, Vertical SaaS, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hyro Comps
Public and private peers based on sector, stage, and business model.
Hyro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic Growth Round | Oct 21, 2025 | ||||
| Growth Equity | Oct 21, 2025 | ||||
| Series B Extension | Dec 10, 2024 | ||||
| Series B | May 31, 2023 | ||||
| Series A | May 25, 2021 | ||||
Seed | Jul 1, 2018 |
Key People
Founding team and executive leadership
Hyro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Define Ventures | Strategic Growth Round, Growth Equity |
| Spero Ventures | Series B, Series A |
| Liberty Mutual Strategic Ventures | Series B |
| Entrepreneurs Roundtable Accelerator | Series A, Seed |
| Macquarie Group | Series B |
| Hanaco VC | Series A, Series B |
| K20 Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
New research released on AI adoption by U.S. health systems.
- Mar 4, 2026
Partnered with Overlake Medical Center & Clinics to modernize patient access operations.
Hyro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hyro's valuation, stock price, and market status.
